Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival

Background: A higher rate of cancer in systemic sclerosis (SSc) is recognized but the role of SSc-linked autoantibodies status (positive/negative and autoantibody specificities) in the survival of SSc-patients with cancer remains poorly understood. Methods: We utilized the Clalit-Health-Services med...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Abdulla Watad, Dennis McGonagle, Nicola L. Bragazzi, Shmuel Tiosano, Doron Comaneshter, Yehuda Shoenfeld, Arnon D. Cohen, Howard Amital
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis Group 2019-06-01
Colecção:OncoImmunology
Assuntos:
systemic sclerosis
scleroderma
malignancy
cancer
autoantibodies
autoimmune diseases
Acesso em linha:http://dx.doi.org/10.1080/2162402X.2019.1588084
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados